Cost-Minimisation Analysis of Subcutaneous vs Intravenous Rituximab for the Treatment of Follicular Lymphoma and Diffuse Large B-Cell Lymphoma in Singapore
Abstract
Authors
MH Choi S Lim A Wong
MH Choi S Lim A Wong
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now